The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy

Previously we reported that mithramycin represses multiple pathways critical for stem cell signaling and pluripotency in lung cancer cells. This phenomenon coincided with decreased side population fraction and dramatic dose-dependent growth arrest of lung cancer cells in vitro and in vivo. In the pr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Am Thorac Soc
Päätekijät: Zhang, Mary R., Xi, Sichuan, Shukla, Vivek, Hong, Julie A., Chen, Haobin, Xiong, Yin, Ripley, R. Taylor, Hoang, Chuong D., Schrump, David S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Thoracic Society 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946505/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201707-608MG
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia